Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue

Ian A Cree, Sharon Glaysher, Alan L Harvey

Research output: Contribution to journalLiterature review

70 Citations (Scopus)

Abstract

The discovery of anti-cancer drugs has become dependent on cell lines, which are used to screen potential compounds for activity as well as to explore cancer biology. Cell lines produce rapid results, but their relevance to patient outcomes is questionable as they undergo selection over many passages to a point where they are no longer representative of their originating tumour. This has led to the increasing use of primary cell cultures, primary tumour cell explants, early passage cell lines, and xenografts to improve the accuracy of results during drug development. Over the last few years, there has been an increasing interest in these methods and they are now firmly established, with a plethora of different techniques available. For instance, explant and three-dimensional models allow cell:cell interactions to be examined in live cells, and endpoints can include the measurement of gene expression and image analysis. In the future, anti-cancer drug development is likely to use a combination of molecular, cell line, primary or early passage cell culture, and xenograft methods for lead optimisation before clinical trials are contemplated.
Original languageEnglish
Pages (from-to)375-9
Number of pages5
JournalCurrent Opinion in Pharmacology
Volume10
Issue number4
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Cell Line
Neoplasms
Heterografts
Pharmaceutical Preparations
Primary Cell Culture
Cell Communication
Cell Culture Techniques
Clinical Trials
Gene Expression

Keywords

  • antineoplastic agents
  • cell communication
  • cells
  • drug screening assays
  • humans
  • models
  • neoplasms
  • antitumor

Cite this

@article{d3e10cd65a9e4c488062e8bafe4f37f6,
title = "Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue",
abstract = "The discovery of anti-cancer drugs has become dependent on cell lines, which are used to screen potential compounds for activity as well as to explore cancer biology. Cell lines produce rapid results, but their relevance to patient outcomes is questionable as they undergo selection over many passages to a point where they are no longer representative of their originating tumour. This has led to the increasing use of primary cell cultures, primary tumour cell explants, early passage cell lines, and xenografts to improve the accuracy of results during drug development. Over the last few years, there has been an increasing interest in these methods and they are now firmly established, with a plethora of different techniques available. For instance, explant and three-dimensional models allow cell:cell interactions to be examined in live cells, and endpoints can include the measurement of gene expression and image analysis. In the future, anti-cancer drug development is likely to use a combination of molecular, cell line, primary or early passage cell culture, and xenograft methods for lead optimisation before clinical trials are contemplated.",
keywords = "antineoplastic agents, cell communication, cells, drug screening assays, humans, models, neoplasms, antitumor",
author = "Cree, {Ian A} and Sharon Glaysher and Harvey, {Alan L}",
note = "Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.",
year = "2010",
month = "8",
doi = "10.1016/j.coph.2010.05.001",
language = "English",
volume = "10",
pages = "375--9",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
number = "4",

}

Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. / Cree, Ian A; Glaysher, Sharon; Harvey, Alan L.

In: Current Opinion in Pharmacology, Vol. 10, No. 4, 08.2010, p. 375-9.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue

AU - Cree, Ian A

AU - Glaysher, Sharon

AU - Harvey, Alan L

N1 - Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.

PY - 2010/8

Y1 - 2010/8

N2 - The discovery of anti-cancer drugs has become dependent on cell lines, which are used to screen potential compounds for activity as well as to explore cancer biology. Cell lines produce rapid results, but their relevance to patient outcomes is questionable as they undergo selection over many passages to a point where they are no longer representative of their originating tumour. This has led to the increasing use of primary cell cultures, primary tumour cell explants, early passage cell lines, and xenografts to improve the accuracy of results during drug development. Over the last few years, there has been an increasing interest in these methods and they are now firmly established, with a plethora of different techniques available. For instance, explant and three-dimensional models allow cell:cell interactions to be examined in live cells, and endpoints can include the measurement of gene expression and image analysis. In the future, anti-cancer drug development is likely to use a combination of molecular, cell line, primary or early passage cell culture, and xenograft methods for lead optimisation before clinical trials are contemplated.

AB - The discovery of anti-cancer drugs has become dependent on cell lines, which are used to screen potential compounds for activity as well as to explore cancer biology. Cell lines produce rapid results, but their relevance to patient outcomes is questionable as they undergo selection over many passages to a point where they are no longer representative of their originating tumour. This has led to the increasing use of primary cell cultures, primary tumour cell explants, early passage cell lines, and xenografts to improve the accuracy of results during drug development. Over the last few years, there has been an increasing interest in these methods and they are now firmly established, with a plethora of different techniques available. For instance, explant and three-dimensional models allow cell:cell interactions to be examined in live cells, and endpoints can include the measurement of gene expression and image analysis. In the future, anti-cancer drug development is likely to use a combination of molecular, cell line, primary or early passage cell culture, and xenograft methods for lead optimisation before clinical trials are contemplated.

KW - antineoplastic agents

KW - cell communication

KW - cells

KW - drug screening assays

KW - humans

KW - models

KW - neoplasms

KW - antitumor

UR - http://www.scopus.com/inward/record.url?scp=77955275498&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2010.05.001

DO - 10.1016/j.coph.2010.05.001

M3 - Literature review

VL - 10

SP - 375

EP - 379

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 4

ER -